Works matching IS 10837159 AND DT 2019 AND VI 24 AND IP 3
Results: 26
The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
A Cost‐Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First‐Line Intermediate‐ to Poor‐Risk Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 366, doi. 10.1634/theoncologist.2018-0656
- By:
- Publication type:
- Article
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 385, doi. 10.1634/theoncologist.2018-0442
- By:
- Publication type:
- Article
Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 293, doi. 10.1634/theoncologist.2018-0387
- By:
- Publication type:
- Article
Resolution of Pembrolizumab‐Associated Steroid‐Refractory Lichenoid Dermatitis with Cyclosporine.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. e103, doi. 10.1634/theoncologist.2018-0531
- By:
- Publication type:
- Article
T‐Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor Prognosis.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. e106, doi. 10.1634/theoncologist.2018-0422
- By:
- Publication type:
- Article
Exploring Biomarkers of Phosphoinositide 3‐Kinase Pathway Activation in the Treatment of Hormone Receptor Positive, Human Epidermal Growth Receptor 2 Negative Advanced Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 305, doi. 10.1634/theoncologist.2018-0314
- By:
- Publication type:
- Article
Somebody Tell Me.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 423, doi. 10.1634/theoncologist.2018-0080
- By:
- Publication type:
- Article
Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 291, doi. 10.1634/theoncologist.2018-0565
- By:
- Publication type:
- Article
Patient‐Centered Oncology or Population‐Centered Oncology—Which Do We Want, and Which Tradeoffs Are We Willing To Accept?
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 288, doi. 10.1634/theoncologist.2018-0679
- By:
- Publication type:
- Article
Protecting Patient Privacy in Narratives: The Lifespan‐Brown Checklist for Appropriate Use of Patient Narratives.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 285, doi. 10.1634/theoncologist.2018-0659
- By:
- Publication type:
- Article
You and Whose Army?
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 421, doi. 10.1634/theoncologist.2018-0720
- By:
- Publication type:
- Article
First‐in‐Human Phase I Study of MBC‐11, a Novel Bone‐Targeted Cytarabine‐Etidronate Conjugate in Patients with Cancer‐Induced Bone Disease.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 303, doi. 10.1634/theoncologist.2018-0707
- By:
- Publication type:
- Article
Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 301, doi. 10.1634/theoncologist.2018-0696
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 394, doi. 10.1634/theoncologist.2018-0195
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Magnetic Resonance Imaging‐Based Screening for Asymptomatic Brain Tumors: A Review.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 375, doi. 10.1634/theoncologist.2018-0177
- By:
- Publication type:
- Article
Venous Thromboembolism in Patients with Sarcoma: A Retrospective Study.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. e111, doi. 10.1634/theoncologist.2018-0081
- By:
- Publication type:
- Article
Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 349, doi. 10.1634/theoncologist.2018-0150
- By:
- Publication type:
- Article
Genomic Landscape of Adult and Pediatric BCR‐ABL1‐Like B‐Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 372, doi. 10.1634/theoncologist.2018-0272
- By:
- Publication type:
- Article
Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 313, doi. 10.1634/theoncologist.2018-0213
- By:
- Publication type:
- Article
The Current and Evolving Landscape of First‐Line Treatments for Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 338, doi. 10.1634/theoncologist.2018-0267
- By:
- Publication type:
- Article
Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 402, doi. 10.1634/theoncologist.2018-0086
- By:
- Publication type:
- Article
Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 414, doi. 10.1634/theoncologist.2018-0184
- By:
- Publication type:
- Article
Effectiveness of First‐Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 358, doi. 10.1634/theoncologist.2017-0314
- By:
- Publication type:
- Article
Impact of Patient Age on Molecular Alterations of Left‐Sided Colorectal Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 319, doi. 10.1634/theoncologist.2018-0117
- By:
- Publication type:
- Article